M4MM

Trulieve Reports Q3 2025 Financial Results

TALLAHASSEE – Trulieve Cannabis Corp. disclosed third-quarter results showing revenue of $288 million, edging up 1% from the year-ago period but dipping 5% from the second quarter. The figures highlight a push toward tighter operations ...

Spain Cabinet Greenlights Medical Cannabis Framework

MADRID – Spain's Council of Ministers on Tuesday approved a royal decree that sets rules for prescribing Cannabis-based medicines through the public health system, marking the first formal step toward regulated access for patients facing ...

Trulieve Reports Q3 2025 Financial Results

TALLAHASSEE – Trulieve Cannabis Corp. disclosed third-quarter results showing revenue of $288 million, edging up 1% from the year-ago period but dipping 5% from the second quarter. The figures highlight a push toward tighter operations ...

DEA Postpones Cannabis Rescheduling Hearing to 2025

LOS ANGELES- The Drug Enforcement Administration (DEA) has postponed its public hearing on the proposed rescheduling of cannabis under federal law. Initially scheduled for December 2, 2024, the hearing is now expected to occur in ...

What You Need to Know About Cash Flow Management

NEW YORK- Every CFO and entrepreneur in Cannabis and Psychedelics needs to know that efficient cash flow management is essential in the cannabis industry, where companies face specific financial challenges. WELCOME Back to this fresh ...

Cansortium Completes Merger with RIV Capital

LOS ANGELES- Cansortium Inc., operating under the Fluent brand, has finalized its merger with RIV Capital Inc., establishing a multi-state cannabis operator with a presence in Florida, New York, Texas, and Pennsylvania. The merger results ...

Psyence Biomed Completes $2 Million Private Placement

LOS ANGELES- Psyence Biomedical Ltd. , a biotechnology firm specializing in psilocybin-based psychedelic medicines, has finalized a private placement, securing approximately $2 million in gross proceeds. The financing involved the issuance of 1,000,000 common shares ...

Psyence Biomedical Regains Nasdaq Compliance

LOS ANGELES- Psyence Biomedical Ltd. (Nasdaq: PBM) has regained compliance with all Nasdaq continued listing requirements, as confirmed by the Nasdaq Hearings Panel. The company had previously requested a transfer from The Nasdaq Global Market ...

MariMed Launches Wholesale Cannabis Operations in Missouri

LOS ANGELES- MariMed Inc, a multi-state cannabis operator, has initiated wholesale operations in Missouri, marking its expansion into a sixth revenue-generating state. The company's premium product lines—including Betty’s Eddies™ fruit chews, Bubby’s Baked™ confections, Vibations™ ...

LEEF Brands Closes CAD $500K Financing Round

LOS ANGELES- LEEF Brands Inc. , a California-based cannabis extraction and manufacturing company, has successfully closed the second tranche of its private placement financing, securing an additional CAD $500,000. This follows the first tranche, which ...

FDA Restricts Psychoactive Mushroom in Edibles

LOS ANGELES- The U.S. Food and Drug Administration (FDA) has issued a warning regarding the use of Amanita muscaria (fly agaric) mushrooms and their psychoactive compounds—muscimol, ibotenic acid, and muscarine—in food products. The FDA has ...

Subscribe To Our Newsletter